Clinically, overexpression of GLUT1/3 and HK2 was associated with poor clinical outcomes, including more advanced tumor stage, greater tumor burden, higher rate of recurrence and poor survival in HCC patients [19,32,36]. This evidence concerns the gene HK2 and hepatocellular carcinoma.